Huberman Lab
Dr. Peter Attia: Supplements for Longevity & Their Efficacy
Dr. Peter Attia
If it sounds like I'm machinating, I am. Let me say it again. If you limited the analysis to people who had below 27% on this hepatic fat index, the people who got the full dose had no difference. They averaged 20% at the beginning of the trial and 19% at the end, no statistically significant difference. The placebo group averaged 20% at the beginning, 20% at the end.
0
💬
0
Comments
Log in to comment.
There are no comments yet.